GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kopran Ltd (NSE:KOPRAN) » Definitions » Net Income Including Noncontrolling Interests

Kopran (NSE:KOPRAN) Net Income Including Noncontrolling Interests : ₹529 Mil (TTM As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Kopran Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Kopran's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2024 was ₹74 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 was ₹529 Mil.

Kopran Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Kopran's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kopran Net Income Including Noncontrolling Interests Chart

Kopran Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 210.20 616.06 610.31 272.33 509.56

Kopran Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 137.70 157.94 186.20 110.95 73.84

Kopran Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹529 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kopran Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Kopran's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Kopran Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kopran Ltd (NSE:KOPRAN) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
BOM:532815 BOM:524774 BOM:507747 BOM:543500 NSE:MARKSANS LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568 TSE:4519
Traded in Other Exchanges
524280:India
Address
Dr. E. Moses Road, 1076, Parijat House, Worli, Mumbai, MH, IND, 400 018
Website
https://www.kopran.com
Kopran Ltd is an Indian based pharmaceutical company. It is engaged in manufacturing of Formulation (Finished Dosage Form) and Active Pharmaceutical Ingredients (API) i.e., Pharmaceuticals. It manufactures dosage forms including, tablets, capsules, dry powder, suspension, and injectables. Some of its product range includes antibiotics, cardiovascular, anti-diabetes, respiratory, pain management, and gastrointestinal. Geographically, it has a presence in India; South Africa; Ethiopia; Zambia; Egypt; Jordan and Rest of World.

Kopran Headlines

No Headlines